Inhibitory effect of dietary inulin or oligofructose on the development of cancer metastases

H S Taper1, M B Roberfroid

  • 1Unité de Pharmacocinétique, Métabolisme, Nutrition et Toxicologie, Université Catholique de Louvain, Avenue Em. Mounier, 73,UCL/PMNT 7369, B 1200 Bruxelles, Belgium. ferdinand@pmnt.ucl.ac.be

Anticancer Research
|February 24, 2001
PubMed

Insights

Dietary inulin or oligofructose significantly inhibited liver tumor lung metastasis in mice. This dietary intervention reduced the incidence and number of lung metastases, suggesting a potential therapeutic role.

Area of Science:

  • Oncology
  • Nutrition Science
  • Gastroenterology

Background:

  • Liver cancer is a significant global health concern.
  • Metastasis, particularly to the lungs, is a major cause of mortality in liver cancer patients.
  • Dietary interventions are increasingly explored for cancer prevention and treatment.

Purpose of the Study:

  • To investigate the effect of dietary inulin and oligofructose on the development of lung metastases from a transplantable liver tumor.
  • To evaluate the inhibitory potential of these prebiotics on tumor metastasis.

Main Methods:

  • Young male C3H mice were used in the study.
  • Mice received continuous dietary treatment with 15% inulin or oligofructose.
  • Microscopical examination was performed to assess lung metastases.

Main Results:

  • Dietary inulin and oligofructose showed a distinct inhibitory effect on lung metastasis development.
  • The percentage of mice with lung metastases was 59% (control), 36% (inulin), and 35% (oligofructose).
  • The total number of lung metastases was significantly reduced: 37 (control), 18 (inulin), and 6 (oligofructose).

Conclusions:

  • Continuous dietary intake of inulin or oligofructose effectively inhibits the development of lung metastases from liver tumors.
  • These prebiotics demonstrate a promising role in reducing cancer metastasis.
  • Further research into the underlying mechanisms of this inhibition is warranted.